West Pharmaceutical Services, Inc.

WST

Market Cap$27.62B

Close$

Compare West Pharmaceutical Services

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
West Pharmaceutical Services, Inc.	46.5	0.21%	21%	9.8	0.1
Market Avg	59	1.3%	30%	-	1
Healthcare Avg	64.4	1.34%	15%	-	0.9

$536.00

Target Price by Analysts

37.4% upsideWest Pharmaceutical Services Target Price Details

$157.09

Current Fair Value

59.7% downside

Overvalued by 59.7% based on the discounted cash flow analysis.

Share Statistics

Market cap	$27.62 Billion
Enterprise Value	$26.98 Billion
Dividend Yield	$0.7796 (0.21%)
Earnings per Share	$7.88
Beta	1.07
Outstanding Shares	73,205,367
Avg 30 Day Volume	329,100

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	46.55
PEG	141.02
Price to Sales	9.76
Price to Book Ratio	10.01
Enterprise Value to Revenue	9.14
Enterprise Value to EBIT	37.2
Enterprise Value to Net Income	45
Total Debt to Enterprise	0.01
Debt to Equity	0.07

Revenue Sources

No data

ESG Score

No data

About West Pharmaceutical Services, Inc.

CEO: Eric Green